
Public Health
How Human Challenge Trials Can Accelerate Vaccine Development
Studies in which subjects volunteer to be infected with a disease reduce the uncertainties and bottlenecks of other types of trials
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account